Treatment of Intestinal Parasitic Diseases

Therapy of Digestive Disorders

Volumn , Issue , 2006, Pages 745-754

  Richter, Joachim ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646794742     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0317-5.50058-3     Document Type: Chapter

References (59)

1. Bouchet F, Petrequin F, Paicheler PC First paleoparasitologic approach to the Neolithic site in Chalain, Jura, France. Bull Soc Path Exot 1995, 88:265-268.
2. Bouchet F Recovery of helminth eggs from archeological excavations of the Grand Louvre (Paris). J Parasitol 1995, 81(5):785-787.
3. Gonçalves MLC, Silva VL, Andrade CM, et al. Amoebiasis distribution in the past: first steps using an immunoassay technique. Trans R Soc Trop Med Hyg 2004, 98:88-91.
4. Deelder AM, Miller RL, de Jonge N, et al. Detection of schistosome antigen in mummies. Lancet 1990, I:724-725.
5. Engels D, Sinzinkayo E, Gryseels B Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications. Am J Trop Med Hyg 1996, 54:319-324.
6. Engels D, Sinzinkayo E, Gryseels B Intraspecimen fecal egg count variation in Schistosoma mansoni infection. Am J Trop Med Hyg 1997, 57:571-577.
7. Farthing MJG, Cevallos AM, Kelly P Intestinal protozoa. Manson's tropical diseases 2002, 1373-1430. Saunders, London. 21st edn. G.C. Cook, A. Zumla (Eds.).
8. Goka AK, Rolston DD, Mathan VI, et al. The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg 1990, 84(1):66-67.
9. Gupta SK, Croffie JM, Pfefferkorn MD, et al. Diagnostic yield of duodenal aspirate for G. lamblia and comparison to duodenal mucosal biopsies. Dig Dis Sci 2003, 48(3):605-607.
10. Brinkmann UK, Powollik W, Werler C, et al. An evaluation of sampling methods within communities and the validity of parasitological examination techniques in the field. Trop Med Parasitol 1988, 39:162-166.
11. Ritchie LS An ether sedimentation technique for routine stool examinations. Bull US Army Med Dept 1948, 8:326.
12. Teesdale CH, Amin MA Comparison of the Bell technique and a digestion method for the field diagnosis of schistosomiasis mansoni. J Helminthol 1970, 50:17-20.
13. Katz N, Chaves A, Pellegrino J A simple device for quantitative thick smear technique in schistosomiasis mansoni. Rev Inst Med Trop S Paulo 1990, 14:97-100.
14. Marti HP, Escher E SAF - an alternative fixation solution for parasitological specimens. Schweiz Med Wochenschr 1990, 120:1473-1476.
15. Lumbreras H, Cantella R, Bengra R Acerca de un procedimiento de sedimentación rápida para investigar huevos de Fasciola hepatica en las heces, su evaluación y uso en el campo. Rev Med Peruana 1962, 31:167-174.
16. Cheesbrough M District Laboratory practice in tropical countries. part 1: parasitology, clinical chemistry, management, quality control 1998, Tropical Health Technology, Doddington, UK.
17. Harada Y, Mori O A new method for culturing hook-worm. Trop Dis Bull 1956, 53:343.
18. Koga K, Kasuya S, Khamboonruang C, et al. A modified agar plate method for detection of Strongyloides stercoralis. Am J Trop Med Hyg 1991, 45(4):518-521.
19. Espino AM, Finlay CM Sandwich enzyme linked immunosorbent assay for detection of excretory-secretory antigens in humans with fascioliasis. J Clin Microbiol 1994, 32:190-193.
20. Hunter's tropical medicine and emerging infectious diseases 2000, WB Saunders, London. 8th edn. G.T. Strickland (Ed.).
21. Moody AH Clinical laboratory diagnosis. Manson's tropical diseases 2002, 1615-1628. WB Saunders, London. 21st edn. G.C. Cook, A. Zumla (Eds.).
22. Diamond LS, Clark CG A redescription of Entamoeba histolytica Shaudinn, 1903 (amended Walker, 1911) separating it from Entamoeba dispa brumpt, 1925. J Euk. Microbiol 1993, 40:340-344.
23. Richter J, Hatz C, Häussinger D Ultrasound in tropical and parasitic diseases. Lancet 2003, 362:900-902.
24. Mearin F, Roset M, Badia X, et al. Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol 2004, 99(1):122-130.
25. Addiss DG, Mathews HM, Stewart JM, et al. Evaluation of a commercially available enzyme-linked immunosorbent assay for Giardia lamblia antigen in stool. J Clin Microbiol 1991, 29(6):1137-1142.
26. Aldeen WE, Carroll K, Robison A, et al. Comparison of nine commercially available enzyme-linked immunosorbent assays for detection of Giardia lamblia in fecal specimens. J Clin Microbiol 1998, 36(5):1338-1340.
27. Aziz H, Beck CE, Lux MF, et al. A comparison study of different methods used in the detection of Giardia lamblia. Clin Lab Sci 2001, 14(3):150-154.
28. Hanson KL, Cartwright CP Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia. J Clin Microbiol 2001, 39(2):474-477.
29. Fedorko DP, Williams EC, Nelson NA, et al. Performance of three enzyme immunoassays and two direct fluorescence assays for detection of Giardia lamblia in stool specimens preserved in ECOFIX. J Clin Microbiol 2001, 38(7):2781-2783.
30. Neal KR, Hebden J, Spiller R Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. Br Med J 1997, 314(7083):779-782.
31. Cacopardo B, Patamia I, Bonaccorso V, et al. Efficacia sinergica dell'associazione albendazolo-metronidazolo nella giardiasi refrattaria a monoterapia con metronidazolo. Clinica terapeutica 1995, 146:761-767.
32. Zaat JOM, Mank TG, Assendelft WJJ A systematic review on the treatment of giardiasis. Trop Med Int Hlth 1997, 2(1):63-82.
33. Nash TE, Ohl CA, Thomas E, et al. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001, 33:22-28.
34. Arjona R, Riancho JA, Aguado JM, et al. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine-Baltimore 1995, 74(1):13-23.
35. Richter J, Knipper M, Göbels K, et al. Fascioliasis. Curr Treatment Options Infect Dis 2002, 4:313-317.
36. Mairiang E, Mairiang P Clinical manifestations of opistorchiasis and treatment. Acta Trop 2003, 88:221-227.
37. Lambertucci JR Schistosomiasis mansoni: pathological and clinical aspects. Human schistosomiasis 1993, 195-235. CAB International, Wallingford, Oxon, UK. P. Jordan, G. Webbe, R.F. Sturrock (Eds.).
38. Richter J, Stegemann U, Häussinger D Hydrocele in a young boy with Schistosoma mansoni infection. Brit J Urol 2002, 89:1-2.
39. D'Alessandro A Polycystic echinococcosis in tropical America: E. vogeli and E. oligarthrus. Acta Trop 1997, 67:43-65.
40. Gottstein B, Reichen J Echinococcosis/hydatidosis. Manson's tropical diseases 2002, 1561-1582. WB Saunders, London. 21st edn. G.C. Cook, A. Zumla (Eds.).
41. Kern P Echinococcus granulosus infection: clinical presentation, medical treatment and outcome. Langenbeck's Arch Surg 2003, 388:413-420.
42. Ripert C, Couprie B, Moyou R, et al. Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon, a pilot study. Trans R Soc Trop Med Hyg 1992, 86:417.
43. Calvopiña M, Guderian RH, Paredes W, et al. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 1998, 92:566-569.
44. Millán JC, Mull R, Freise S, et al. Efficacy and tolerability of triclabendazol for the treatment of latent and chronic fascioliasis. Am J Trop Med Hyg 2000, 63:264-269. the Triclabendazole Study Group.
45. Levi GC, de Avila CA, Amato Neto V Efficacy of various drugs for treatment of giardiasis. A comparative study. Am J Trop Med Hyg 1977, 26(3):564-565.
46. Li S, Swu L, Liu Z, et al. Studies on the prophylactic effect of artesunate on schistosomiasis japonica. Chin Med J 1996, 109:848-853.
47. De Clercq D, Vercruysse J, Verle P, et al. Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal. Trans R Soc Trop Med Hyg 2000, 94:90-91.
48. Rossignol JF, Abaza H, Friedman H Successful treatment of human fascioliasis with nitazoxanide. Trans R Soc Trop Med Hyg 1998, 92:103-104.
49. Gilles HM, Hoffman PS Treatment of intestinal parasitic infections: areview of nitazoxanide. Trends Parasitol 2002, 18(3):95-97.
50. Armadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002, 360:1375-1380.
51. Stelma FF, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an endemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995, 53:167-170.
52. Cioli D Chemotherapy of schistosomiasis: an update. Parasitol Today 1998, 14:418-422.
53. Blessmann J, Tannich E Treatment of asymptomatic intestinal Entamoeba histolytica infection. N Engl J Med 2003, 347(17):1384.
54. Abdi YA, Gustafsson LL, Ericsson Ö, et al. Handbook for tropical parasitic infections 1995, Taylor & Francis, London. 2nd edn.
55. Gann PH, Neva FA, Gam AA A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994, 169:1076-1079.
56. Datry A, Hilmasrsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole; results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994, 88:344-345.
57. Bradley M, Horton J Assessing the risk of benzimidazole therapy during pregnancy. Trans R Soc Trop Med Hyg 2001, 95(1):737.
58. Olds GR Administration of praziquantel to pregnant and lactating women. Acta Trop 2003, 86(2-3):185-195.
59. Molina JM, Tourneur M, Sarfati C, et al. Agence Nationale de Recherches sur le SIDA 090 Study Group. Fumagillin treatment of intestinal microsporidiosis. N Engl J Med 2002, 20(25):346. 1963-1969.